Drug
Vca 894a
Vca 894a: highest development phase Phase 1/2, developed by Vanda Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Vanda Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VCA-894A NCT07223632 | Phase 1/2 | Charcot Marie Tooth Disease (CMT) |
Latest
No recent events.
Follow Vca 894a on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.